Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FP6S7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,051
Award facts
- Contract value 100% obligated
- $53,051.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,051.40 delivery order to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials under a firm fixed-price contract. The order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a competitively awarded procurement with no set-aside designation. IMFINZI (durvalumab) is a prescription immunotherapy medication used in cancer treatment. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical distributor within the federal medical supply chain.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability to meet federal procurement requirements for specialized medical commodities.
Quick answers
Who was awarded contract SPE2DB25FP6S7?
SPE2DB25FP6S7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FP6S7 worth?
The government has obligated $53,051 on SPE2DB25FP6S7.
Is contract SPE2DB25FP6S7 an order under another contract?
Yes. SPE2DB25FP6S7 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP6S7 competed?
The extent of competition for SPE2DB25FP6S7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award